Video

Emerging Psychedelic Therapies

Author(s):

Alexander Somjen

Here's why psychedelics might be a valuable addition to mental health treatment.

Alexander Somjen discusses the fragmented psychedelic industry, regulatory frameworks, and potential commercial success.

Alexander Somjen is the CEO and Director of Origin Therapeutics.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!
Related Videos
psychedelics MDMA FDA CRL
Psychiatric Times Experts Weight in on FDA Advisory Decision for PTSD
ketamine
Related Content
movement disorders
October 1st 2025

Movement Disorders in Psychiatric Practice

Haitham Salem, MD, PhD Gabriel A. de Erausquin, MD, PhD Antonio L. Teixeira, MD, PhD
Here's to a Psychedelic Revolution
October 1st 2025

Here's to a Psychedelic Revolution

Amir Inamdar MBBS, DNB (Psych), MFPM
cannabis
October 1st 2025

Cannabis Use Is Booming in Older Adults: Are We Ready?

Haley V. Solomon, DO Aaron Greenstein, MD
How to Talk to Teenagers About Substance Use
October 1st 2025

How to Talk to Teenagers About Substance Use

Hannah Simon, MD
clinical trial zervimesine smoking nicotine addiction
October 1st 2025

Study on Zervimesine for Alzheimer Disease Reaches Enrollment Target

Jessica Walters
smoking cessation new drug application cytisinicline
October 1st 2025

FDA Accepts New Drug Application for Cytisinicline for Smoking Cessation

Jessica Walters
© 2025 MJH Life Sciences

All rights reserved.